SCHEMBL5525624

SCHEMBL5525624

CC(=NNC(N)=S)c1ccccc1-c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.61
METTL3 Q86U44 1/20 0.61
CTSK P43235 2/20 0.52
CYP1A2 P05177 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5525621 1.00 ATM (0.61) ATMMETTL3CTSKCYP1A2
SCHEMBL941216 0.79 ATM (0.63) ATMMETTL3CTSK
SCHEMBL941840 0.79 ATM (0.62) ATMMETTL3
SCHEMBL30523857 0.79 ATM (0.62) ATMMETTL3
SCHEMBL5528604 0.79 ATM (0.62) ATMMETTL3
SCHEMBL4332229 0.78 METTL3 (0.81) ATMMETTL3CTSK
SCHEMBL941479 0.78 ATM (0.60) ATMMETTL3
SCHEMBL940551 0.78 CTSL (0.60) ATMMETTL3
SCHEMBL4332234 0.78 METTL3 (0.81) ATMMETTL3CTSK
SCHEMBL941415 0.78 ALDH1A1 (0.71) ATMMETTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197495-A1 ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-08-23 US disclosed
EP-1734939-A1 ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE The Regents of The University of California (US) 2006-12-27 EP disclosed
WO-2005087211-A1 ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197495-A1 ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE CYP51A1, TUBA3C, PIGO ATM 4843/4885METTL3 4301/4885CTSK 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.